Personalized Tamoxifen: What Is the Best Way Forward?

被引：7

作者：

Rae, James M. ^{[1
]}

机构：

[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 24期

关键词：

AROMATASE INHIBITORS; CYP2D6; METABOLISM; PHARMACOGENOMICS; PREDICTOR; GENOTYPE; EXPOSURE; ESTROGEN; OUTCOMES; WOMEN;

D O I：

10.1200/JCO.2011.36.3895

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3206 / 3208

页数：4

共 23 条

[1]

Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0

[2] Effect of screening and adjuvant therapy on mortality from breast cancer [J].

Berry, DA ;

Cronin, KA ;

Plevritis, SK ;

Fryback, DG ;

Clarke, L ;

Zelen, M ;

Mandelblatt, JS ;

Yakovlev, AY ;

Habbema, JDF ;

Feuer, EJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792

[3] Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism:: Implication for optimization of breast cancer treatment [J].

Borges, Silvana ;

Desta, Zeruesenay ;

Li, Lang ;

Skaar, Todd C. ;

Ward, Bryan A. ;

Nguyen, Anne ;

Jin, Yan ;

Storniolo, Anna Maria ;

Nikoloff, D. Michele ;

Wu, Lin ;

Hillman, Grant ;

Hayes, Daniel F. ;

Stearns, Vered ;

Flockhart, David A. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (01) :61-74

[4] Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment [J].

de Graan, Anne-Joy M. ;

Teunissen, Sebastiaan F. ;

de Vos, Filip Y. F. L. ;

Loos, Walter J. ;

van Schaik, Ron H. N. ;

de Jongh, Felix E. ;

de Vos, Aad I. ;

van Alphen, Robbert J. ;

van der Holt, Bronno ;

Verweij, Jaap ;

Seynaeve, Caroline ;

Beijnen, Jos H. ;

Mathijssen, Ron H. J. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) :3240-3246

[5] Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the arimidex, tamoxifen, alone or in combination trial [J].

Dowsett, Mitch ;

Allred, Craig ;

Knox, Jill ;

Quinn, Emma ;

Salter, Janine ;

Wale, Chris ;

Cuzick, Jack ;

Houghton, Joan ;

Williams, Norman ;

Mallon, Elizabeth ;

Bishop, Hugh ;

Ellis, Ian ;

Larsimont, Denis ;

Sasano, Hironobu ;

Carder, Pauline ;

Cussac, Antonio Llombart ;

Knox, Fiona ;

Speirs, Valerie ;

Forbes, John ;

Buzdar, Aman .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) :1059-1065

[6] Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen [J].

Dowsett, Mitch ;

Cuzick, Jack ;

Ingle, Jim ;

Coates, Alan ;

Forbes, John ;

Bliss, Judith ;

Buyse, Marc ;

Baum, Michael ;

Buzdar, Aman ;

Colleoni, Marco ;

Coombes, Charles ;

Snowdon, Claire ;

Gnant, Michael ;

Jakesz, Raimund ;

Kaufmann, Manfred ;

Boccardo, Francesco ;

Godwin, Jon ;

Davies, Christina ;

Peto, Richard .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) :509-518

[7] Tamoxifen pharmacogenomics: The role of CYP2D6 as a predictor of drug response [J].

Goetz, M. P. ;

Kamal, A. ;

Ames, M. M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) :160-166

[8] Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes [J].

Goetz, MP ;

Rae, JM ;

Suman, VJ ;

Safgren, SL ;

Ames, MM ;

Visscher, DW ;

Reynolds, C ;

Couch, FJ ;

Lingle, WL ;

Flockhart, DA ;

Desta, Z ;

Perez, EA ;

Ingle, JN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9312-9318

[9] A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer [J].

Hatzis, Christos ;

Pusztai, Lajos ;

Valero, Vicente ;

Booser, Daniel J. ;

Esserman, Laura ;

Lluch, Ana ;

Vidaurre, Tatiana ;

Holmes, Frankie ;

Souchon, Eduardo ;

Wang, Hongkun ;

Martin, Miguel ;

Cotrina, Jose ;

Gomez, Henry ;

Hubbard, Rebekah ;

Ignacio Chacon, J. ;

Ferrer-Lozano, Jaime ;

Dyer, Richard ;

Buxton, Meredith ;

Gong, Yun ;

Wu, Yun ;

Ibrahim, Nuhad ;

Andreopoulou, Eleni ;

Ueno, Naoto T. ;

Hunt, Kelly ;

Yang, Wei ;

Nazario, Arlene ;

DeMichele, Angela ;

O'Shaughnessy, Joyce ;

Hortobagyi, Gabriel N. ;

Symmans, W. Fraser .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (18) :1873-1881

[10] A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients? [J].

Hayes, Daniel F. ;

Steams, Vered ;

Rae, James ;

Flockhart, David .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09) :610-613

← 1 2 3 →